LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens

Immunology

Volumn 131, Issue 3, 2010, Pages 318-330

  Crotzer, Victoria L ^a   Glosson, Nicole ^a   Zhou, Delu ^a   Nishino, Ichizo ^b   Blum, Janice S ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Exogenous antigens; Human B cells; MHC class II presentation

Indexed keywords

ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; DAUDI CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN FUNCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS, SURFACE; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; GLYCOGEN STORAGE DISEASE TYPE IIB; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHOCYTE ACTIVATION; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; MICE; MUTATION; PEPTIDE FRAGMENTS; PROTEIN BINDING;

EID: 78649405008     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03309.x     Document Type: Article

References (47)

1. Watts C. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat Immunol 2004; 5:685-92.
2. Cresswell P. Invariant chain structure and MHC class II function. Cell 1996; 84:505-7.
3. Sant AJ, Miller J. MHC class II antigen processing: biology of invariant chain. Curr Opin Immunol 1994; 6:57-63.
4. Maric MA, Taylor MD, Blum JS. Endosomal aspartic proteinases are required for invariant-chain processing. Proc Natl Acad Sci U S A 1994; 91:2171-5.
5. Riese RJ, Wolf PR, Bromme D, Natkin LR, Villadangos JA, Ploegh HL, Chapman HA. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996; 4:357-66.
6. Watts C. Antigen processing in the endocytic compartment. Curr Opin Immunol 2001; 13:26-31.
7. Sherman MA, Weber DA, Jensen PE. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 1995; 3:197-205.
8. Sloan VS, Cameron P, Porter G, Gammon M, Amaya M, Mellins E, Zaller DM. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995; 375:802-6.
9. Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 1995; 82:155-65.
10. Pieters J. MHC class II compartments: specialized organelles of the endocytic pathway in antigen presenting cells. Biol Chem 1997; 378:751-8.
11. Cuervo AM, Dice JF. Lysosomes, a meeting point of proteins, chaperones, and proteases. J Mol Med 1998; 76:6-12.
12. Dell'Angelica EC, Mullins C, Caplan S, Bonifacino JS. Lysosome-related organelles. FASEB J 2000; 14:1265-78.
13. Eskelinen EL, Tanaka Y, Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol 2003; 13:137-45.
14. Danon MJ, Oh SJ, DiMauro S, Manaligod JR, Eastwood A, Naidu S, Schliselfeld LH. Lysosomal glycogen storage disease with normal acid maltase. Neurology 1981; 31:51-7.
15. Nishino I, Fu J, Tanji K et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 2000; 406:906-10.
16. Tanaka Y, Guhde G, Suter A et al. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 2000; 406:902-6.
17. Eskelinen EL, Illert AL, Tanaka Y, Schwarzmann G, Blanz J, Von Figura K, Saftig P. Role of LAMP-2 in lysosome biogenesis and autophagy. Mol Biol Cell 2002; 13:3355-68.
18. Konecki DS, Foetisch K, Zimmer KP, Schlotter M, Lichter-Konecki U. An alternatively spliced form of the human lysosome-associated membrane protein-2 gene is expressed in a tissue-specific manner. Biochem Biophys Res Commun 1995; 215:757-67.
19. Zhou D, Li P, Lin Y, Lott JM, Hislop AD, Canaday DH, Brutkiewicz RR, Blum JS. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 2005; 22:571-81.
20. Cuervo AM, Dice JF. A receptor for the selective uptake and degradation of proteins by lysosomes. Science 1996; 273:501-3.
21. Cuervo AM, Dice JF. Unique properties of lamp2a compared to other lamp2 isoforms. J Cell Sci 2000; 113(Pt 24):4441-50.
22. Majeski AE, Dice JF. Mechanisms of chaperone-mediated autophagy. Int J Biochem Cell Biol 2004; 36:2435-44.
23. Pathak SS, Lich JD, Blum JS. Cutting edge: editing of recycling class II: peptide complexes by HLA-DM. J Immunol 2001; 167:632-5.
24. Pathak SS, Blum JS. Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules. Traffic 2000; 1:561-9.
25. Ma C, Whiteley PE, Cameron PM et al. Role of APC in the selection of immunodominant T cell epitopes. J Immunol 1999; 163:6413-23.
26. Kovats S, Whiteley PE, Concannon P, Rudensky AY, Blum JS. Presentation of abundant endogenous class II DR-restricted antigens by DM-negative B cell lines. Eur J Immunol 1997; 27:1014-21.
27. Woods A, Chen HY, Trumbauer ME, Sirotina A, Cummings R, Zaller DM. Human major histocompatibility complex class II-restricted T cell responses in transgenic mice. J Exp Med 1994; 180:173-81.
28. Hiraiwa A, Yamanaka K, Kwok WW, Mickelson EM, Masewicz S, Hansen JA, Radka SF, Nepom GT. Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis. Proc Natl Acad Sci U S A 1990; 87:8051-5.
29. Lampson LA, Levy R. Two populations of Ia-like molecules on a human B cell line. J Immunol 1980; 125:293-9.
30. Gruneberg U, Rich T, Roucard C, Marieke van Ham S, Charron D, Trowsdale J. Two widely used anti-DR alpha monoclonal antibodies bind to an intracellular C-terminal epitope. Hum Immunol 1997; 53:34-8.
31. Cresswell P, Arunachalam B, Bangia N, Dick T, Diedrich G, Hughes E, Maric M. Thiol oxidation and reduction in MHC-restricted antigen processing and presentation. Immunol Res 1999; 19:191-200.
32. Hsing LC, Rudensky AY. The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol Rev 2005; 207:229-41.
33. Villadangos JA, Bryant RA, Deussing J et al. Proteases involved in MHC class II antigen presentation. Immunol Rev 1999; 172:109-20.
34. Denzin LK, Sant'Angelo DB, Hammond C, Surman MJ, Cresswell P. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 1997; 278:106-9.
35. Ramachandra L, Kovats S, Eastman S, Rudensky AY. Variation in HLA-DM expression influences conversion of MHC class II alpha beta: class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line. J Immunol 1996; 156:2196-204.
36. Lich JD, Jayne JA, Zhou D, Elliott JF, Blum JS. Editing of an immunodominant epitope of glutamate decarboxylase by HLA-DM. J Immunol 2003; 171:853-9.
37. Zhou D, Blum JS. Presentation of cytosolic antigens via MHC class II molecules. Immunol Res 2004; 30:279-90.
38. Wicker LS, Chen SL, Nepom GT et al. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest 1996; 98:2597-603.
39. Lenmark A. Glutamic acid decarboxylase - gene to antigen to disease. J Intern Med 1996; 240:259-77.
40. Storkus WJ, Zeh HJ, Salter RD, Lotze MT. Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J Immunother Emphasis Tumor Immunol 1993; 14:94-103.
41. Avva RR, Cresswell P. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1994; 1:763-74.
42. Beertsen W, Willenborg M, Everts V, Zirogianni A, Podschun R, Schroder B, Eskelinen EL, Saftig P. Impaired phagosomal maturation in neutrophils leads to periodontitis in lysosomal-associated membrane protein-2 knockout mice. J Immunol 2008; 180:475-82.
43. Faigle W, Raposo G, Tenza D et al. Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndrome. J Cell Biol 1998; 141:1121-34.
44. Barbosa MD, Nguyen QA, Tchernev VT et al. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 1996; 382:262-5.
45. Nagle DL, Karim MA, Woolf EA et al. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 1996; 14:307-11.
46. Perou CM, Leslie JD, Green W, Li L, Ward DM, Kaplan J. The Beige/Chediak-Higashi syndrome gene encodes a widely expressed cytosolic protein. J Biol Chem 1997; 272:29790-4.
47. Chicz RM, Urban RG, Gorga J, Vignali DA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993; 178:27-47.